BMJ:新型风险模型用以预测糖尿病患者失明和截肢的风险

2015-11-13 MedSci MedSci原创

BMJ:新型风险模型用以预测糖尿病患者失明和截肢的风险是否能够设计一种风险预测模型用以评估25-48岁2型糖尿病患者失明和下肢截除的10年风险?

是否能够设计一种风险预测模型用以评估25-48岁2型糖尿病患者失明和下肢截除的10年风险?

采用前瞻性队列研究分析方法,分析了1998-2014年来自CPRD数据库的资料。共纳入了763项 QResearch实践(共 454 575名糖尿病患者),254项已经验证过QResearch实践(n = 142 419)以及357项CPRD实践(n = 206 050)。使用Cox比例风险模型分别评估男性和女性失明和截肢的10年风险。计算两队列的区分度和校准度。

研发用以定量预测男性及女性糖尿病患者失眠和截肢绝对风险的预测方程,并进行外部验证。随访期间,QResearch队列中新出现4822例下肢截肢病例和8063例失明病例。两个已验证队列中风险方程均进行了很好的校准。CPRD队列中男性截肢(D statistic 1.40, Harrell’s C statistic 0.73)和失明 (D statistic 1.40, Harrell’s C statistic 0.73)的区分度较好,与QResearch队列中女性的区分度结果相似。该算法是基于患者很可能知道或已常规记录于常规实践计算机系统来计算的。他们可用于识别高风险的患者,以防止失明和截肢的发生或对此行进一步的评估。该算法的局限性包括缺乏正式的裁定结果,信息偏倚以及数据丢失。

糖尿病可增加患者失明和截肢的风险,但一般没有用于准确评估患者个体失明和截肢风险的方法。本研究中新的算法计算出糖尿病患者的10年失明和截肢发生的绝对风险,并考虑到患者的个体危险因素。

原始出处:


Julia Hippisley-Cox,Carol Coupland. Development and validation of risk prediction equations to estimate future risk of blindness and lower limb amputation in patients with diabetes: cohort study. BMJ 2015; 351 doi: http://dx.doi.org/10.1136/bmj.h5441 (Published 11 November 2015)

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1847753, encodeId=f4ac184e753f2, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Nov 24 03:48:00 CST 2015, time=2015-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388158, encodeId=1277138815843, content=<a href='/topic/show?id=e51454180b6' target=_blank style='color:#2F92EE;'>#截肢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54180, encryptionId=e51454180b6, topicName=截肢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1292500019, createdName=124984edm22暂无昵称, createdTime=Sun Nov 15 00:48:00 CST 2015, time=2015-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457382, encodeId=86eb145e38226, content=<a href='/topic/show?id=36ea100885d0' target=_blank style='color:#2F92EE;'>#风险模型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100885, encryptionId=36ea100885d0, topicName=风险模型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18b75898745, createdName=wjywjy, createdTime=Sun Nov 15 00:48:00 CST 2015, time=2015-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473920, encodeId=705114e39202e, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun Nov 15 00:48:00 CST 2015, time=2015-11-15, status=1, ipAttribution=)]
    2015-11-24 gaoxiaoe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1847753, encodeId=f4ac184e753f2, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Nov 24 03:48:00 CST 2015, time=2015-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388158, encodeId=1277138815843, content=<a href='/topic/show?id=e51454180b6' target=_blank style='color:#2F92EE;'>#截肢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54180, encryptionId=e51454180b6, topicName=截肢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1292500019, createdName=124984edm22暂无昵称, createdTime=Sun Nov 15 00:48:00 CST 2015, time=2015-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457382, encodeId=86eb145e38226, content=<a href='/topic/show?id=36ea100885d0' target=_blank style='color:#2F92EE;'>#风险模型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100885, encryptionId=36ea100885d0, topicName=风险模型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18b75898745, createdName=wjywjy, createdTime=Sun Nov 15 00:48:00 CST 2015, time=2015-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473920, encodeId=705114e39202e, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun Nov 15 00:48:00 CST 2015, time=2015-11-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1847753, encodeId=f4ac184e753f2, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Nov 24 03:48:00 CST 2015, time=2015-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388158, encodeId=1277138815843, content=<a href='/topic/show?id=e51454180b6' target=_blank style='color:#2F92EE;'>#截肢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54180, encryptionId=e51454180b6, topicName=截肢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1292500019, createdName=124984edm22暂无昵称, createdTime=Sun Nov 15 00:48:00 CST 2015, time=2015-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457382, encodeId=86eb145e38226, content=<a href='/topic/show?id=36ea100885d0' target=_blank style='color:#2F92EE;'>#风险模型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100885, encryptionId=36ea100885d0, topicName=风险模型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18b75898745, createdName=wjywjy, createdTime=Sun Nov 15 00:48:00 CST 2015, time=2015-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473920, encodeId=705114e39202e, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun Nov 15 00:48:00 CST 2015, time=2015-11-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1847753, encodeId=f4ac184e753f2, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Nov 24 03:48:00 CST 2015, time=2015-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388158, encodeId=1277138815843, content=<a href='/topic/show?id=e51454180b6' target=_blank style='color:#2F92EE;'>#截肢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54180, encryptionId=e51454180b6, topicName=截肢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1292500019, createdName=124984edm22暂无昵称, createdTime=Sun Nov 15 00:48:00 CST 2015, time=2015-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457382, encodeId=86eb145e38226, content=<a href='/topic/show?id=36ea100885d0' target=_blank style='color:#2F92EE;'>#风险模型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100885, encryptionId=36ea100885d0, topicName=风险模型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18b75898745, createdName=wjywjy, createdTime=Sun Nov 15 00:48:00 CST 2015, time=2015-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473920, encodeId=705114e39202e, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun Nov 15 00:48:00 CST 2015, time=2015-11-15, status=1, ipAttribution=)]

相关资讯

Lancet Dia & Endo:小心糖代谢异常,它可能会让你面临终生糖尿病

对于CaHD与瓣膜置换手术相关的手术死亡率有所下降。症状和生存的好处是,当CaHD由经验丰富的多学科团队管理时还会产生症状性和生存利益。

《中国糖尿病医学营养治疗指南》的更新与发展

近几十年中,全球糖尿病患者数以惊人的速度增长。2007年全球约有2.46亿人患有糖尿病,预计到2030年,糖尿病患者将达3.8亿,且大部分将集中于发展中国家。中华医学会糖尿病学分会于2007至2008年对中国14个省市自治区的48 431名20岁以上人群进行糖尿病筛查。结果显示,糖尿病和糖尿病前期的患病率分别为9.7%和15.5%,估计中国受糖尿病影响的人数将达到9 240万。另据2013年《

AHA 2015:多吃家常饭能降低患2型糖尿病的风险率!

近日,美国心脏协会科学会议上发布了一项最新的研究成果,经常在家自制膳食用餐可预防2型糖尿病的发生。以往,关于经常在餐馆用餐所带来的负面健康影响(特别是快餐店)早有新闻报道。例如,在今年的上半年时今日医学新闻报道的一项研究结果发现,经常摄入高热量和高盐的食物可能会导致体重增加、血压、糖尿病和心脏病的风险因素。但是,尽管人们清楚认识到经常在外用餐并不有利健康,然而似乎有更多的人愿意选择外出就餐,而不是

BMJ:外科病房高钾血症病例分析

56岁女性,因膝盖以下截肢后残端感染入院。既往史:2型糖尿病并发足溃疡和周围神经病变。规律服用二甲双胍、兰索拉唑、Humulin I和Novorapid SC胰岛素、阿司匹林、对乙酰氨基酚、硫酸吗啡、加巴喷丁、卡马西平。住院期间还皮下注射达肝素钠5000U/d、静注青霉素和氟氯西林。住院前,血清钾浓度 4.6-4.8 mmol/L(参考范围3.6-5.0)。住院期间,持续高钾血症,最高达6.2 m

母义明:干细胞治疗2型糖尿病的现状与未来

11月06日,由生物谷主办的2015(第七届)干细胞技术与临床转化论坛在上海君衡城市酒店举行。来自清华大学医学院、解放军总医院内分泌科的母义明主任参加了本次大会,并且在会上分享了关于"干细胞治疗2型糖尿病的现状与未来"的精彩报告。 母义明主任首先分析了我国的糖尿病患病趋势逐渐严峻,以及对于2型糖尿病(T2DM)病因、机理的研究仍没有突破性进展的现状。随后母义明主任介绍了他的课题组研究了间充质

Diabetes Care:孕早期腹部脂肪,有助于妊娠期糖尿病高危人群的识别

最新研究表明,孕早期腹部脂肪的增加或导致妊娠期糖尿病风险的增加。该研究纳入了500名女性,年龄18-42岁,通过超声测量孕11-14周的腹部脂肪情况。数据显示腹部脂肪越多的女性在孕24-28周诊断为妊娠期糖尿病的可能性越大。但是该研究仅仅提供了两者间的相关性,并不是因果性。该研究强调了孕早期的筛查,通过腹部脂肪预测糖尿病发生情况。仅仅在常规产前检查的时候,留意下孕早期女性腹部脂肪情况,就可以识别妊